Neuronetics Past Earnings Performance
Past criteria checks 0/6
Neuronetics's earnings have been declining at an average annual rate of -3.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 6.2% per year.
Key information
-3.1%
Earnings growth rate
8.6%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 6.2% |
| Return on equity | -388.3% |
| Net Margin | -50.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Neuronetics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 73 | -36 | 73 | 9 |
| 30 Jun 24 | 72 | -32 | 72 | 9 |
| 31 Mar 24 | 73 | -28 | 72 | 9 |
| 31 Dec 23 | 71 | -30 | 73 | 10 |
| 30 Sep 23 | 69 | -33 | 73 | 10 |
| 30 Jun 23 | 68 | -31 | 73 | 11 |
| 31 Mar 23 | 67 | -37 | 75 | 10 |
| 31 Dec 22 | 65 | -37 | 75 | 9 |
| 30 Sep 22 | 62 | -37 | 73 | 8 |
| 30 Jun 22 | 59 | -37 | 71 | 7 |
| 31 Mar 22 | 57 | -34 | 67 | 7 |
| 31 Dec 21 | 55 | -31 | 63 | 8 |
| 30 Sep 21 | 56 | -27 | 59 | 8 |
| 30 Jun 21 | 55 | -22 | 52 | 9 |
| 31 Mar 21 | 50 | -23 | 48 | 8 |
| 31 Dec 20 | 49 | -27 | 51 | 9 |
| 30 Sep 20 | 51 | -31 | 53 | 11 |
| 30 Jun 20 | 55 | -35 | 58 | 13 |
| 31 Mar 20 | 61 | -34 | 62 | 14 |
| 31 Dec 19 | 63 | -29 | 60 | 14 |
| 30 Sep 19 | 61 | -28 | 60 | 12 |
| 30 Jun 19 | 59 | -26 | 58 | 10 |
| 31 Mar 19 | 55 | -26 | 55 | 9 |
| 31 Dec 18 | 53 | -24 | 52 | 8 |
| 30 Sep 18 | 49 | -23 | 48 | 8 |
| 30 Jun 18 | 46 | -22 | 44 | 8 |
| 31 Mar 18 | 43 | -17 | 39 | 7 |
| 31 Dec 17 | 40 | -16 | 36 | 8 |
| 31 Dec 16 | 34 | -11 | 29 | 8 |
Quality Earnings: NRC is currently unprofitable.
Growing Profit Margin: NRC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NRC is unprofitable, and losses have increased over the past 5 years at a rate of 3.1% per year.
Accelerating Growth: Unable to compare NRC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NRC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: NRC has a negative Return on Equity (-388.26%), as it is currently unprofitable.